Related Experiment Videos
Knowledge, perceptions, and readiness to use electronic pharmacy services among the Syrian population: A
Mohammad Basheer Alameer1, Zahra Kabbani2, Reem Alsamara2
1Faculty of Medicine, Damascus University, Damascus, Syria.
Digital Health
|July 2, 2026
Summary
Syrian adults have positive views on e-pharmacy services but low adoption rates. Enhancing digital literacy and infrastructure is key to integrating electronic pharmacy into healthcare.
Area of Science:
- Digital Health
- Pharmaceutical Services
- Public Health
Background:
- E-pharmacy adoption is growing globally, yet data from Syria remains limited.
- Understanding public perception is crucial for integrating digital health solutions.
Purpose of the Study:
- To assess knowledge, perceptions, and readiness for e-pharmacy services among Syrian adults.
- To identify demographic factors influencing awareness and readiness for e-pharmacy adoption.
Main Methods:
- A cross-sectional online survey was conducted with 600 Syrian adults (≥18 years).
- Data collected included demographics, e-pharmacy awareness/use, perceived benefits/drawbacks, and adoption readiness.
- Statistical analysis identified predictors of knowledge and readiness.
Main Results:
- 50.2% were aware of e-pharmacy; only 14.3% had used it.
- High agreement on benefits (convenience, time-saving, epidemic protection); moderate concerns (privacy, errors).
- 53.7% were willing to use e-pharmacy, particularly for adherence monitoring and medication reviews.
Conclusions:
- Syrian adults exhibit favorable perceptions and moderate readiness for e-pharmacy.
- Low adoption necessitates addressing digital infrastructure, literacy, and regulatory frameworks.
- Integrating e-pharmacy can enhance Syria's digital health ecosystem.
Related Concept Videos
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...